| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Department of Cancer Cell Research, Institute of Medical Science, University of Tokyo, Shirokanedai, Minato-ku, Tokyo 108 [N. H., M. S. S., T. K.], Japan; Department of Pathology, Faculty of Medicine, University of Tokyo, Hongo, Bunkyo-ku, Tokyo 113 [J. S.], Japan; and Institut für Zellbiologie (Tumorforschung), Universitat Essen (GH), D-4300 Essen 1 [M. F. R.], Federal Republic of Germany
The detection and quantitation of carcinogen-DNA adducts in human cells are the key parameters in the molecular dosimetry of human exposure to environmental carcinogens. For investigating the possible relevance of alkylating N-nitroso compounds as causative agents in human carcinogenesis, we have quantitated O4-ethyl-2'-deoxythymidine (O4-EtdThd) in human liver DNA obtained from 33 autopsy specimens, i.e., 13 cases with primary liver cancer (LC), 8 with cancers other than liver cancer (OC), and 12 with noncancerous diseases (NC). None of the cases analyzed had a history of known occupational exposure to ethylating agents. The detection limit for O4-EtdThd was 3 x 10-8 as a O4-EtdThd/dThd molar ratio in DNA, which was attained by the combination of prefractionation of DNA hydrolysates (= 20 mg of DNA/sample) by high performance liquid chromatography and competitive radioimmunoassay using anti-(O4-EtdThd) monoclonal antibody ER-01. Except for one case in each group, O4-EtdThd [or, alternatively, (an) unidentified structural modification(s) of DNA recognized by monoclonal antibody ER-01] was detected at mean (± SD) O4-EtdThd/dThd molar ratios of 39.9 ± 40.2 x 10-8, 53.5 ± 74.0 x 10-8, and 11.7 ± 6.5 x 10-8, respectively, in LC, OC, and NC. The difference of the O4-EtdThd content in DNA between LC and NC, or between LC + OC and NC, was statistically significant at P < 0.05. These results suggest that humans are exposed to ethylating agents in vivo and that a premutagenic DNA lesion (O4-EtdThd) eventually accumulates in DNA, possibly to a biologically significant extent.
1 This work was supported in part by grants for Cancer Research and for Special Project Research, Cancer-Bioscience from the Ministry of Education, Science and Culture of Japan and by the Deutsche Forschungsgemeinschaft (SFB 102/A7).
2 To whom requests for reprints should be addressed, at the Department of Cancer Cell Research, Institute of Medical Science, University of Tokyo, Shirokanedai, Minato-ku, Tokyo 108, Japan.
Received 6/27/88. Revised 9/19/88. Accepted 9/30/88.
This article has been cited by other articles:
![]() |
A. C. Povey DNA Adducts: Endogenous and Induced Toxicol Pathol, May 1, 2000; 28(3): 405 - 414. [Abstract] [PDF] |
||||
![]() |
R. M. Santella Immunological Methods for Detection of Carcinogen-DNA Damage in Humans Cancer Epidemiol. Biomarkers Prev., September 1, 1999; 8(9): 733 - 739. [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |